IL133461A - Adefovir dipivoxil compositions - Google Patents

Adefovir dipivoxil compositions

Info

Publication number
IL133461A
IL133461A IL13346198A IL13346198A IL133461A IL 133461 A IL133461 A IL 133461A IL 13346198 A IL13346198 A IL 13346198A IL 13346198 A IL13346198 A IL 13346198A IL 133461 A IL133461 A IL 133461A
Authority
IL
Israel
Prior art keywords
compositions
adefovir dipivoxil
dipivoxil
adefovir
dipivoxil compositions
Prior art date
Application number
IL13346198A
Other languages
English (en)
Other versions
IL133461A0 (en
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26732226&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL133461(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of IL133461A0 publication Critical patent/IL133461A0/xx
Publication of IL133461A publication Critical patent/IL133461A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transplanting Machines (AREA)
IL13346198A 1997-07-25 1998-07-23 Adefovir dipivoxil compositions IL133461A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5377197P 1997-07-25 1997-07-25
US90074597A 1997-07-25 1997-07-25
PCT/US1998/015304 WO1999004774A2 (en) 1997-07-25 1998-07-23 Nucleotide analog compositions

Publications (2)

Publication Number Publication Date
IL133461A0 IL133461A0 (en) 2001-04-30
IL133461A true IL133461A (en) 2005-05-17

Family

ID=26732226

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13346198A IL133461A (en) 1997-07-25 1998-07-23 Adefovir dipivoxil compositions

Country Status (24)

Country Link
EP (1) EP0996430B1 (zh)
JP (4) JP3573713B2 (zh)
KR (3) KR100618663B1 (zh)
CN (2) CN1216062C (zh)
AR (1) AR016548A1 (zh)
AT (3) ATE277936T1 (zh)
AU (1) AU747163B2 (zh)
BR (1) BR9811552A (zh)
CA (3) CA2596320C (zh)
CO (1) CO4980869A1 (zh)
DE (3) DE69826734T2 (zh)
DK (1) DK0996430T3 (zh)
ES (3) ES2229030T3 (zh)
HK (5) HK1046357B (zh)
ID (1) ID28006A (zh)
IL (1) IL133461A (zh)
IN (1) IN190037B (zh)
MY (1) MY129451A (zh)
NZ (1) NZ501659A (zh)
PT (3) PT1256585E (zh)
SI (2) SI1256584T1 (zh)
TR (3) TR200000224T2 (zh)
TW (1) TW584635B (zh)
WO (1) WO1999004774A2 (zh)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9811552A (pt) * 1997-07-25 2000-08-29 Gilead Sciences Inc Composições de análogos de nucleotìdeos
US6635278B1 (en) * 1998-12-15 2003-10-21 Gilead Sciences, Inc. Pharmaceutical formulations
TWI230618B (en) * 1998-12-15 2005-04-11 Gilead Sciences Inc Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
AU2001282941C1 (en) 2000-07-21 2016-12-22 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
EP1532157A4 (en) 2002-05-13 2009-02-25 Metabasis Therapeutics Inc NEW PRODRUGS FROM PMEA TO PHOSPHONIC ACID BASE AND ITS ANALOG
US7193081B2 (en) 2002-05-13 2007-03-20 Metabasis Therapeutics, Inc. Process for preparation of cyclic prodrugs of PMEA and PMPA
KR101101962B1 (ko) * 2002-11-12 2012-01-02 티안진 디실리 인베스트먼트 홀딩 그룹, 리미티드 새로운 결정 형태를 가진 아데포비어 디피복실의 제조 방법
CN100383149C (zh) * 2002-11-12 2008-04-23 天津帝士力投资控股集团有限公司 一种新的晶状埃地双酯及其组合物
CN1303089C (zh) * 2002-11-19 2007-03-07 天津药物研究院 阿德福韦酯结晶形态及其制备方法
CN100415756C (zh) * 2003-10-14 2008-09-03 沈阳药科大学 草酸阿地福韦酯及其晶型和制备方法及用途
CN100358907C (zh) * 2004-03-31 2008-01-02 河北医科大学生物医学工程中心 一种非晶状阿德福韦酯的制备方法
CN100374118C (zh) * 2004-05-20 2008-03-12 江苏吴中中药研发有限公司 含有阿德福韦酯的滴丸剂及其制备方法
KR20070029196A (ko) 2004-06-08 2007-03-13 메타베이시스 테라퓨틱스, 인크. 고리 에스테르의 루이스 산 매개 합성
CN102240296B (zh) * 2005-06-13 2013-04-03 博瑞生物医药技术(苏州)有限公司 泰诺福韦的固体
CN100395248C (zh) * 2006-05-26 2008-06-18 华东理工大学 一种9-(二乙氧基磷酰基甲氧基乙基)-腺嘌啉的制备方法
ITMI20071594A1 (it) * 2007-08-02 2009-02-03 Solmag Spa Forma cristallina monoidrata di adefovir dipivoxil
CN101343290B (zh) * 2008-05-24 2011-02-02 广东肇庆星湖生物科技股份有限公司 一种阿德福韦酯无水结晶物的制备方法、所得的阿德福韦酯无水结晶物及其应用
WO2010005195A2 (ko) * 2008-07-07 2010-01-14 (주)아모레퍼시픽 아데포버 디피복실의 결정형 ｌ의 제조방법
KR20100031045A (ko) 2008-09-11 2010-03-19 씨제이제일제당 (주) 아데포비어 디피복실의 정제방법
JP2012502902A (ja) * 2008-09-17 2012-02-02 シージェイ チェルジェダン コーポレイション アデホビルジピボキシルの安定化した固体分散体及びその製造方法
KR20100032803A (ko) 2008-09-18 2010-03-26 씨제이제일제당 (주) 아데포비어디피복실의 개선된 제조방법
KR20100061401A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 아데포버 디피복실의 결정형, 그 제조방법 및 그를 포함하는 약제학적 조성물
CN102365283B (zh) * 2009-03-26 2014-04-09 株式会社大熊制药 阿德福韦酯的新晶型及其制备方法
KR20100113302A (ko) * 2009-04-13 2010-10-21 한미홀딩스 주식회사 결정형 아데포비어 디피복실의 제조방법 및 이에 사용되는 아데포비어 디피복실 부탄올레이트
KR101528754B1 (ko) * 2009-04-14 2015-06-17 중앙대학교 산학협력단 신규한 복합결정형의 화합물, 그 제조방법 및 이를 포함하는 약제학적 조성물
KR100971486B1 (ko) * 2009-06-11 2010-07-21 주식회사 셀트리온화학연구소 아데포비어 다이피복실 말론산염 및 이를 포함하는 약제학적 조성물
KR101089620B1 (ko) * 2009-07-20 2011-12-06 경희대학교 산학협력단 무수결정형 아데포비어 디피복실 및 이온성 액체를 사용한 이의 제조 방법
WO2011016611A2 (ko) * 2009-08-03 2011-02-10 제일약품주식회사 새로운 결정형을 갖는 아데포비어 디피복실, 이의 제조방법 및 이를 유효성분으로 함유하는 만성 ｂ형 간염의 예방 또는 치료용 조성물
KR101129575B1 (ko) * 2009-09-02 2012-03-28 경희대학교 산학협력단 반수화물 아데포비어 디피복실 및 이온성 액체를 사용한 이의 제조 방법
KR101048024B1 (ko) * 2009-10-09 2011-07-13 주식회사 삼오제약 9-(2-포스포닐메톡시에틸)아데닌, 아데포비아 디피복실 및 무정형 아데포비아 디피복실의 제조방법
EP2343056A1 (en) 2009-12-30 2011-07-13 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Producing stable adefovir dipivoxil solid dispersions
WO2012032541A1 (en) * 2010-09-06 2012-03-15 Matrix Laboratories Ltd "adefovir dipivoxil pseudopolymorph"
WO2012062835A1 (en) 2010-11-12 2012-05-18 Glaxo Wellcome Manufacturing Pte Ltd Novel pharmaceutical compositions
CN102250146A (zh) * 2011-05-27 2011-11-23 扬州三友合成化工有限公司 抗乙肝药物阿德福韦的一种合成方法
KR101357687B1 (ko) * 2011-11-25 2014-02-05 숭실대학교산학협력단 고분자 첨가제를 이용한 아데포비어 디피복실 복합체의 결정입자 제어방법 및 이의 응용
KR101258678B1 (ko) 2012-02-29 2013-04-26 제일약품주식회사 새로운 결정형을 갖는 아데포비어 디피복실, 이의 제조방법 및 이를 유효성분으로 함유하는 만성 β형 간염의 예방 또는 치료용 조성물
CN103665043B (zh) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 一种替诺福韦前药及其在医药上的应用
CN102816184B (zh) * 2012-09-07 2015-11-18 山东大学 (2-(2-氧基-4-硫代嘧啶)乙氧基)甲基膦酸酯类衍生物及其制备与应用
CN103709198A (zh) * 2012-09-28 2014-04-09 江苏天士力帝益药业有限公司 一种阿德福韦酯的结晶方法
CN103333208B (zh) * 2013-06-04 2016-05-11 广州晶莱医药科技有限公司 阿德福韦酯马来酸盐及其制备方法和组合物
JP2017512183A (ja) 2014-02-13 2017-05-18 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
EP3372227A1 (en) 2017-03-06 2018-09-12 MH10 Spolka z ograniczona odpowiedzialnoscia Tablet formulation of adefovir dipivoxil
EP3737676B1 (en) 2018-01-09 2024-03-06 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69129650T2 (de) * 1990-09-14 1999-03-25 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic, Prag/Praha Wirkstoffvorläufer von Phosphonaten
CA2126601A1 (en) * 1993-06-29 1994-12-30 Mitsubishi Chemical Corporation Phosphonate-nucleotide ester derivatives
CA2261619C (en) * 1996-07-26 2006-05-23 Gilead Sciences, Inc. Nucleotide analogs
BR9811552A (pt) * 1997-07-25 2000-08-29 Gilead Sciences Inc Composições de análogos de nucleotìdeos

Also Published As

Publication number Publication date
KR100618663B1 (ko) 2006-09-08
MY129451A (en) 2007-04-30
DE69826734T2 (de) 2005-10-06
AU8660998A (en) 1999-02-16
ES2229030T3 (es) 2005-04-16
HK1046357B (zh) 2007-08-24
HK1046357A1 (en) 2003-01-10
CN1347695A (zh) 2002-05-08
HK1091211A1 (en) 2007-01-12
PT996430E (pt) 2003-03-31
KR100700089B1 (ko) 2007-03-28
CA2596320C (en) 2008-12-23
CA2596497C (en) 2008-12-23
TW584635B (en) 2004-04-21
NZ501659A (en) 2004-12-24
SI1256584T1 (en) 2005-02-28
DE69826734D1 (de) 2004-11-04
BR9811552A (pt) 2000-08-29
KR100700087B1 (ko) 2007-03-28
ID28006A (id) 2001-05-03
TR200000224T2 (tr) 2000-07-21
CN1274700C (zh) 2006-09-13
DE69826735T2 (de) 2005-10-06
ATE277937T1 (de) 2004-10-15
JP2009263389A (ja) 2009-11-12
ES2187991T3 (es) 2003-06-16
SI1256585T1 (en) 2005-02-28
KR20060038364A (ko) 2006-05-03
PT1256584E (pt) 2004-12-31
TR200200117T2 (tr) 2002-06-21
ES2229029T3 (es) 2005-04-16
CA2298057C (en) 2008-11-18
ATE228357T1 (de) 2002-12-15
CN1251592A (zh) 2000-04-26
CA2596320A1 (en) 1999-02-04
TR200200137T2 (tr) 2002-09-23
EP0996430A2 (en) 2000-05-03
KR20060038363A (ko) 2006-05-03
PT1256585E (pt) 2005-01-31
WO1999004774A3 (en) 1999-04-15
DE69826735D1 (de) 2004-11-04
AR016548A1 (es) 2001-07-25
JP4452034B2 (ja) 2010-04-21
CO4980869A1 (es) 2000-11-27
CN1216062C (zh) 2005-08-24
AU747163B2 (en) 2002-05-09
JP3573713B2 (ja) 2004-10-06
KR20010014284A (ko) 2001-02-26
JP2005306879A (ja) 2005-11-04
HK1051694A1 (en) 2003-08-15
HK1051693A1 (en) 2003-08-15
DE69809749T2 (de) 2003-09-11
IN190037B (zh) 2003-05-31
ATE277936T1 (de) 2004-10-15
WO1999004774A2 (en) 1999-02-04
CA2596497A1 (en) 1999-02-04
EP0996430B1 (en) 2002-11-27
DE69809749D1 (de) 2003-01-09
DK0996430T3 (da) 2003-03-10
JP2003342283A (ja) 2003-12-03
JP2001512712A (ja) 2001-08-28
IL133461A0 (en) 2001-04-30
CA2298057A1 (en) 1999-02-04
HK1091212A1 (en) 2007-01-12

Similar Documents

Publication Publication Date Title
IL133461A (en) Adefovir dipivoxil compositions
PL346541A1 (en) Glyphosate formulation
HUP9903759A3 (en) Abtimicrobial compositions
HUP0103931A2 (en) Compositions containing diphosphonic acids
GB9827475D0 (en) Compositions
GB9702238D0 (en) Compositions
IL130856A0 (en) Peroxetine compositions
GB9724838D0 (en) Compositions
GB2289408B (en) Glyphosate compositions
GB9705340D0 (en) Compositions
GB9703109D0 (en) Compositions
ZA984837B (en) Phosphate compounds
GB2311991B (en) Organo phosphorus compounds
GB9712981D0 (en) Compositions
GB9717500D0 (en) Phosphoryl compounds
GB2336368B (en) Compositions
GB9704753D0 (en) Glyphosate formulations
GB9713215D0 (en) Compositions
GB9709128D0 (en) Compositions
GB9722734D0 (en) Compositions
GB9719640D0 (en) Compositions
GB9717523D0 (en) Compositions
GB9714273D0 (en) Compositions
GB9708467D0 (en) Compositions
GB9713214D0 (en) Compositions

Legal Events

Date Code Title Description
EXTF Application for patent extension filed
EXTN Extension order renewed
KB Patent renewed
KB Patent renewed
EXTC Patent extension cancelled
KB Patent renewed
EXP Patent expired